OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Longitudinal Immune Response to 3 Doses of Messenger RNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Pediatric Patients Receiving Chemotherapy for Cancer
Thomas Lehrnbecher, Ulrich Sack, Carsten Speckmann, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e510-e513
Open Access | Times Cited: 19
Thomas Lehrnbecher, Ulrich Sack, Carsten Speckmann, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e510-e513
Open Access | Times Cited: 19
Showing 19 citing articles:
Mannan-Decorated Lipid Calcium Phosphate Nanoparticle Vaccine Increased the Antitumor Immune Response by Modulating the Tumor Microenvironment
Liusheng Wu, Lei Yang, Xinye Qian, et al.
Journal of Functional Biomaterials (2024) Vol. 15, Iss. 8, pp. 229-229
Open Access | Times Cited: 5
Liusheng Wu, Lei Yang, Xinye Qian, et al.
Journal of Functional Biomaterials (2024) Vol. 15, Iss. 8, pp. 229-229
Open Access | Times Cited: 5
COVID‐19 Vaccine Response in Pediatric Oncology Patients
Brittni N. Kam, Yiwen Wang, Feifei Qin, et al.
Pediatric Blood & Cancer (2025)
Closed Access
Brittni N. Kam, Yiwen Wang, Feifei Qin, et al.
Pediatric Blood & Cancer (2025)
Closed Access
Immune Response following BNT162b2 mRNA COVID-19 Vaccination in Pediatric Cancer Patients
K. L. Juliëtte Schmidt, Noël Dautzenberg, Peter M. Hoogerbrugge, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2562-2562
Open Access | Times Cited: 10
K. L. Juliëtte Schmidt, Noël Dautzenberg, Peter M. Hoogerbrugge, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2562-2562
Open Access | Times Cited: 10
Humoral profiling of pediatric patients with cancer reveals robust immunity following anti‐SARS‐CoV‐2 vaccination superior to natural infection
Samantha Martin, Nadège Nziza, Pietro Miozzo, et al.
Pediatric Blood & Cancer (2023) Vol. 70, Iss. 8
Open Access | Times Cited: 5
Samantha Martin, Nadège Nziza, Pietro Miozzo, et al.
Pediatric Blood & Cancer (2023) Vol. 70, Iss. 8
Open Access | Times Cited: 5
Pediatric cancer patients vaccinated against SARS-CoV-2—a clinical and laboratory follow-up
Benjamin Siebald, Andreas H. Groll, Sarah Salou, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 4
Open Access | Times Cited: 1
Benjamin Siebald, Andreas H. Groll, Sarah Salou, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 4
Open Access | Times Cited: 1
Long-term immunity after BNT162b2 mRNA COVID-19 vaccination in pediatric patients with cancer
K. L. Juliëtte Schmidt, Noortje R. Severeijns, Noël Dautzenberg, et al.
EJC Paediatric Oncology (2024) Vol. 4, pp. 100172-100172
Closed Access | Times Cited: 1
K. L. Juliëtte Schmidt, Noortje R. Severeijns, Noël Dautzenberg, et al.
EJC Paediatric Oncology (2024) Vol. 4, pp. 100172-100172
Closed Access | Times Cited: 1
Humoral and cellular immune response after mRNA SARS-CoV-2 vaccine in children on treatment for cancer: A pilot observational study
Angela Mastronuzzi, Rita Carsetti, Maria Antonietta De Ioris, et al.
Heliyon (2024) Vol. 10, Iss. 14, pp. e34503-e34503
Open Access | Times Cited: 1
Angela Mastronuzzi, Rita Carsetti, Maria Antonietta De Ioris, et al.
Heliyon (2024) Vol. 10, Iss. 14, pp. e34503-e34503
Open Access | Times Cited: 1
Safety and efficacy of COVID-19 vaccines in children and adolescents with cancer
Nilgün Kurucu, M. Tezer Kutluk, İbrahim Kartal, et al.
The Turkish Journal of Pediatrics (2024) Vol. 66, Iss. 4, pp. 412-420
Open Access | Times Cited: 1
Nilgün Kurucu, M. Tezer Kutluk, İbrahim Kartal, et al.
The Turkish Journal of Pediatrics (2024) Vol. 66, Iss. 4, pp. 412-420
Open Access | Times Cited: 1
BNT162b2 COVID-19 Vaccines in Children, Adolescents and Young Adults with Cancer—A 1-Year Follow-Up
Caroline Donzé, Victoria Min, Läétitia Ninove, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 989-989
Open Access | Times Cited: 4
Caroline Donzé, Victoria Min, Läétitia Ninove, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 989-989
Open Access | Times Cited: 4
Prospective Assessment of Humoral and Cellular Immune Responses to a Third COVID-19 mRNA Vaccine Dose Among Immunocompromised Individuals
Ghady Haidar, Jacob C. Hodges, Andrew Bilderback, et al.
The Journal of Infectious Diseases (2023) Vol. 229, Iss. 5, pp. 1328-1340
Open Access | Times Cited: 4
Ghady Haidar, Jacob C. Hodges, Andrew Bilderback, et al.
The Journal of Infectious Diseases (2023) Vol. 229, Iss. 5, pp. 1328-1340
Open Access | Times Cited: 4
SARS‐CoV‐2 vaccination response in pediatric oncology patients
Amber M. D’Souza, Maria Thomas, Manu Gnanamony, et al.
Pediatric Blood & Cancer (2023) Vol. 71, Iss. 2
Open Access | Times Cited: 4
Amber M. D’Souza, Maria Thomas, Manu Gnanamony, et al.
Pediatric Blood & Cancer (2023) Vol. 71, Iss. 2
Open Access | Times Cited: 4
Humoral and cellular immunity to SARS-CoV-2 following vaccination with non-mRNA vaccines in adolescent/young adults with cancer: A prospective cohort study
Archana Sasi, Jyotsna Dandotiya, Jyotsana Kaushal, et al.
Vaccine (2024) Vol. 42, Iss. 10, pp. 2722-2728
Closed Access
Archana Sasi, Jyotsna Dandotiya, Jyotsana Kaushal, et al.
Vaccine (2024) Vol. 42, Iss. 10, pp. 2722-2728
Closed Access
Rebecca S Parker, Justin Le, Miguel Villa, et al.
International Journal of Cancer (2024) Vol. 155, Iss. 12, pp. 2190-2200
Closed Access
Seroprevalence of SARS‐CoV‐2 in pediatric hematology‐oncology patients
Vivian Phan, Tiana Richards, Keehyo Kang, et al.
Pediatric Blood & Cancer (2024) Vol. 71, Iss. 10
Open Access
Vivian Phan, Tiana Richards, Keehyo Kang, et al.
Pediatric Blood & Cancer (2024) Vol. 71, Iss. 10
Open Access
Kinetics of humoral and cellular immune responses 5 months post-COVID-19 booster dose by immune response groups at the peak immunity phase: An observational historical cohort study using the Fukushima vaccination community survey
Yurie Kobashi, Takeshi Kawamura, Yuzo Shimazu, et al.
Vaccine X (2024) Vol. 20, pp. 100553-100553
Open Access
Yurie Kobashi, Takeshi Kawamura, Yuzo Shimazu, et al.
Vaccine X (2024) Vol. 20, pp. 100553-100553
Open Access
Humoral and Cellular Immune Responses to BNT162b2 COVID-19 Vaccination in Children with Cancer
Amy Body, Luxi Lal, Peter Downie, et al.
(2024)
Closed Access
Amy Body, Luxi Lal, Peter Downie, et al.
(2024)
Closed Access
Vaccination des enfants et adolescents traités pour une leucémie aiguë, hors allogreffés : recommandations du comité leucémies de la Société française de lutte contre les cancers et les leucémies de l’enfant et de l’adolescent (SFCE)
A. M. Roussel, Camille Léglise, Fanny Rialland, et al.
Bulletin du Cancer (2024)
Open Access
A. M. Roussel, Camille Léglise, Fanny Rialland, et al.
Bulletin du Cancer (2024)
Open Access
SARS-COV2 VACCINATION RESPONSE IN PEDIATRIC ONCOLOGY PATIENTS
Amber M. D’Souza, Melanie B. Thomas, Manu Gnanamony, et al.
Authorea (Authorea) (2023)
Open Access
Amber M. D’Souza, Melanie B. Thomas, Manu Gnanamony, et al.
Authorea (Authorea) (2023)
Open Access
Pediatric Cancer Patients Vaccinated Against SARS-CoV-2 – A Clinical and Laboratory Follow-Up
Benjamin Siebald, Andreas H. Groll, Sarah Salou, et al.
Research Square (Research Square) (2023)
Open Access
Benjamin Siebald, Andreas H. Groll, Sarah Salou, et al.
Research Square (Research Square) (2023)
Open Access
